Frazier Life Sciences Management, L.P. Tarsus Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.86 Billion
- Q3 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 1,587,527 shares of TARS stock, worth $84.1 Million. This represents 2.81% of its overall portfolio holdings.
Number of Shares
1,587,527
Previous 1,587,527
-0.0%
Holding current value
$84.1 Million
Previous $43.1 Million
21.01%
% of portfolio
2.81%
Previous 2.54%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
178Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$181 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$173 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$132 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$129 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$119 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.41B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...